leadf
logo-loader
viewHavn Life

Havn Life Sciences to take its magic-mushroom growing firm public this summer

Havn Life Sciences Inc Co-CEO Susan Chapelle tells Proactive the privately-held Vancouver-based biotechnology company is looking to take its magic mushroom-focused firm public, expecting to launch its IPO this summer.

Chapelle says what's more, the firm is progressing with its research in growing psilocybin mushrooms to help fix the restrictive supply-chain issue some firms conducting clinical studies are facing in this space.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Altamira Gold Corp releases positive channel results as the project moves...

Altamira Gold (CVE: ALTA-OTC: EQTRF) CEO Michael Bennett joined Steve Darling from Proactive to share details about the recent work at their at the Cajueiro gold project in Brazil. That trenching work has identified several new mineralized structures. Bennett shared details about that work...

1 hour, 19 minutes ago

2 min read